Pyxis Oncology
PYXS
PYXS
51 hedge funds and large institutions have $15.8M invested in Pyxis Oncology in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 12 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% less funds holding
Funds holding: 54 → 51 (-3)
17% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 12
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
51
Holding in Top 10
2
Calls
$24K
Puts
$2K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$300K | |
| 3 | +$266K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$192K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$37K |
Top Sellers
| 1 | -$826K | |
| 2 | -$146K | |
| 3 | -$93.5K | |
| 4 |
Two Sigma Investments
New York
|
-$50.9K |
| 5 |
Squarepoint
New York
|
-$44.9K |